Publications by authors named "Yoko Inaguma"

Claim this Profile
E
ELC52: a novel megakaryocytic leukemia cell line with a CALR type 1 mutation.
Yukiya Yamamoto, Sachiko Iba, Yoko Inaguma, Akinao Okamoto, Akihiro Abe

Leukemia· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma.
Akinao Okamoto, Hidetsugu Fujigaki, Chisako Iriyama, Naoe Goto, Hideyuki Yamamoto, Yoko Inaguma

Blood Adv· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy.
Nobuhiko Yamauchi, Dai Maruyama, Ilseung Choi, Yoshiko Atsuta, Rika Sakai, Yoko Inaguma

Cancer Sci· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Truncated RUNX1 Generated by the Fusion of RUNX1 to Antisense GRIK2 via a Cryptic Chromosome Translocation Enhances Sensitivity to Granulocyte Colony-Stimulating Factor.
Akihiro Abe, Yukiya Yamamoto, Akira Katsumi, Hideyuki Yamamoto, Akinao Okamoto, Yoko Inaguma

Cytogenet Genome Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of L-Leucine Therapy on Hematopoietic Function in Elderly Myelodysplastic Syndrome Patients.
Kaori Ito, Takahiro Hayashi, Yoko Inaguma, Tomohiko Terazawa, Maiko Ando

Biol Pharm Bull· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Ⅳ.Mantle Cell Lymphoma].
Masataka Okamoto, Yoko Inaguma, Akinao Okamoto

Gan To Kagaku Ryoho· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma arising in patient with a history of EBV-positive mucocutaneous ulcer and EBV-positive nodal polymorphous B-lymphoproliferative disorder.
Teerada Daroontum, Kei Kohno, Yoko Inaguma, Akinao Okamoto, Masataka Okamoto

Pathol Int· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rearrangement of VPS13B, a causative gene of Cohen syndrome, in a case of RUNX1-RUNX1T1 leukemia with t(8;12;21).
Akihiro Abe, Yukiya Yamamoto, Akira Katsumi, Akinao Okamoto, Masutaka Tokuda, Yoko Inaguma

Int J Hematol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS.
Isao Tawara, Shinichi Kageyama, Yoshihiro Miyahara, Hiroshi Fujiwara, Tetsuya Nishida, Yoko Inaguma

Blood· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells.
Akiko Ohashi, Seiichi Kato, Akinao Okamoto, Yoko Inaguma, Akira Satou

Histopathology· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic significance of EBV DNA load and EBER status in diagnostic specimens from diffuse large B-cell lymphoma patients.
Akinao Okamoto, Masamitsu Yanada, Yoko Inaguma, Masutaka Tokuda, Satoko Morishima

Hematol Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of R-CHOP Therapy on Immune System Restoration in Patients with B-Cell Lymphoma.
Kaori Ito, Masataka Okamoto, Yoko Inaguma, Akinao Okamoto, Maiko Ando

Oncology· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a method for calculating carboplatin dosage in DeVIC ± R therapy (combination therapy of dexamethasone, etoposide, ifosfamide and carboplatin with or without rituximab) as a salvage therapy in patients with relapsed or refractory non-Hodgkin lymphoma.
Ayana Tomono, Kaori Ito, Takahiro Hayashi, Maiko Ando, Yosuke Ando, Yoko Inaguma

Cancer Chemother Pharmacol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NUP214-RAC1 and RAC1-COL12A1 Fusion in Complex Variant Translocations Involving Chromosomes 6, 7 and 9 in an Acute Myeloid Leukemia Case with DEK-NUP214.
Akihiro Abe, Yukiya Yamamoto, Sachiko Iba, Akinao Okamoto, Masutaka Tokuda, Yoko Inaguma

Cytogenet Genome Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 mutations in older adults with acute myeloid leukemia.
Masamitsu Yanada, Yukiya Yamamoto, Sachiko Iba, Akinao Okamoto, Yoko Inaguma

Int J Hematol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro antiproliferative activity of 2,3-dihydroxy-9,10-anthraquinone induced apoptosis against COLO320 cells through cytochrome c release caspase mediated pathway with PI3K/AKT and COX-2 inhibition.
C Balachandran, N Emi, Y Arun, N Yamamoto, V Duraipandiyan, Yoko Inaguma

Chem Biol Interact· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ETV6-LPXN fusion transcript generated by t(11;12)(q12.1;p13) in a patient with relapsing acute myeloid leukemia with NUP98-HOXA9.
Akihiro Abe, Yukiya Yamamoto, Sachiko Iba, Tadaharu Kanie, Akinao Okamoto, Yoko Inaguma

Genes Chromosomes Cancer· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of HLA-B*40:02-restricted T cells possessing cytotoxic and suppressive functions against haematopoietic progenitor cells from a patient with severe aplastic anaemia.
Yoko Inaguma, Yoshiki Akatsuka, Kohei Hosokawa, Hiroyuki Maruyama, Akinao Okamoto

Br J Haematol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro anticancer activity of methyl caffeate isolated from Solanum torvum Swartz. fruit.
C Balachandran, N Emi, Y Arun, Y Yamamoto, B Ahilan, Yoko Inaguma

Chem Biol Interact· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma.
Akinao Okamoto, Masamitsu Yanada, Hiroki Miura, Yoko Inaguma, Masutaka Tokuda

Cancer Sci· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The fate of patients with acute myeloid leukemia not undergoing induction chemotherapy.
Masamitsu Yanada, Akinao Okamoto, Yoko Inaguma, Masutaka Tokuda, Satoko Morishima

Int J Hematol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epstein-Barr virus-induced polyclonal lymphoproliferative disorder of lymphoplasmacytic type in an autopsy case of aplastic anemia treated twice with anti-thymocyte globulin therapy.
Eriko Okada, Hiroki Shigeyasu, Yoko Inaguma, Nobuhiko Emi, Kenji Sano

Pathol Int· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of rituximab plus bendamustine chemotherapy on the immune system in patients with refractory or relapsed follicular lymphoma and mantle cell lymphoma.
Kaori Ito, Masataka Okamoto, Maiko Ando, Yukiko Kakumae, Akinao Okamoto, Yoko Inaguma

Leuk Lymphoma· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A varicella outbreak in B-cell lymphoma patients receiving rituximab-containing chemotherapy.
Akinao Okamoto, Akihiro Abe, Masataka Okamoto, Tsukane Kobayashi, Yoko Inaguma

J Infect Chemother· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in outcome for consecutive patients with diffuse large B-cell lymphoma before and after the advent of rituximab: a single-center experience.
Akinao Okamoto, Masamitsu Yanada, Yoko Inaguma, Masutaka Tokuda, Satoko Morishima

Hematology· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis